A Multicenter, Randomized, Double-blind Placebo Controlled Study to Assess the Effect of Rasagiline on Sleep-wake Disturbances in Patients With Parkinson's Disease (PD).

Status: Discontinued

Phase of Trial: Phase IV

Latest Information Update: 14 Jan 2020

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

01 Oct 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
01 Dec 2011 Actual initiation date is Sep 2011 and additional lead trial investigator identified as reported by ClinicalTrials.gov.
01 Dec 2011 Planned end date changed from 1 Nov 2011 to 1 Nov 2013 as reported by ClinicalTrials.gov.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com